Literature DB >> 9122040

Muscarinic cholinergic receptors promote growth of human prostate cancer cells.

W Rayford1, M J Noble, M A Austenfeld, J Weigel, W K Mebust, G V Shah.   

Abstract

BACKGROUND: Recent evidence suggests that muscarinic receptors induce mitogenesis in cells capable of undergoing cell proliferation. Human prostate gland is innervated by the autonomic nervous system and muscarinic receptors have been localized in the prostate gland.
METHODS: Effects of carbachol (a stable analog of acetyl choline) on DNA synthesis of LNCaP cells (a human prostate cancer cell line) and primary prostate cells was examined. The DNA synthesis in the cultured cells was assessed using techniques of 3H-thymidine incorporation and bromodeoxyuridine (BrdU) incorporation immunocytochemistry.
RESULTS: Carbachol induced a significant increase in BrdU- and 3H-thymidine incorporation of LNCaP cells. The effect of carbachol was completely reversed by atropine, a selective muscarinic antagonist. Subtypes of muscarinic receptors mediating carbachol-induced DNA synthesis were identified using selective receptor subtype antagonists. Pirenzepamine and gallamine did not affect carbachol action on LNCaP cells but diphenylpyralamine, an M3 receptor antagonist, completely blocked carbachol-induced DNA synthesis. Carbachol also stimulated DNA synthesis in primary prostate cells. Prostate carcinoma (PC)-derived primary prostate cells displayed a dramatically greater response to carbachol (a ten-fold increase in DNA synthesis) as compared to benign prostate hypertrophy (BPH)-derived cells (a two-fold increase in DNA synthesis).
CONCLUSIONS: M3 receptors stimulate the proliferation of LNCaP cells, BPH-derived and PC-derived primary prostate cells. A dramatically higher response to carbachol by PC-derived prostate cells suggests that M3 receptors may be up-regulated in PC. M3 receptors may play a significant role in PC tumors growth and androgen-independent tumor progression.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9122040     DOI: 10.1002/(sici)1097-0045(19970215)30:3<160::aid-pros3>3.0.co;2-q

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  25 in total

Review 1.  Muscarinic receptors and ligands in cancer.

Authors:  Nirish Shah; Sandeep Khurana; Kunrong Cheng; Jean-Pierre Raufman
Journal:  Am J Physiol Cell Physiol       Date:  2008-11-26       Impact factor: 4.249

2.  GPRC6A regulates prostate cancer progression.

Authors:  Min Pi; L Darryl Quarles
Journal:  Prostate       Date:  2011-06-16       Impact factor: 4.104

Review 3.  Neuronal Activity in Ontogeny and Oncology.

Authors:  Humsa Venkatesh; Michelle Monje
Journal:  Trends Cancer       Date:  2017-02-13

4.  High expression of M3 muscarinic acetylcholine receptor is a novel biomarker of poor prognostic in patients with non-small cell lung cancer.

Authors:  Jun Wu; Jinxu Zhou; Lei Yao; Yaoguo Lang; Yingnan Liang; Lantao Chen; Jinfeng Zhang; Fengjiao Wang; Yanbo Wang; He Chen; Jianqun Ma
Journal:  Tumour Biol       Date:  2013-07-10

5.  Signal transduction by M3 muscarinic acetylcholine receptor in prostate cancer.

Authors:  Liqiang Guo; Yuqiang Liu; Zhibo Ding; Wendong Sun; Mingzhen Yuan
Journal:  Oncol Lett       Date:  2015-10-27       Impact factor: 2.967

6.  Cholinergic facilitation of neurotransmission to the smooth muscle of the guinea-pig prostate gland.

Authors:  W A Lau; J N Pennefather; F J Mitchelson
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

7.  The vagal nerve stimulates activation of the hepatic progenitor cell compartment via muscarinic acetylcholine receptor type 3.

Authors:  David Cassiman; Louis Libbrecht; Nicoletta Sinelli; Valeer Desmet; Carl Denef; Tania Roskams
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

8.  M3 subtype of muscarinic receptors mediate Ca2+ release from intracellular stores in rat prostate neuroendocrine cells.

Authors:  Jin Kyoung Kim; Soo Jung Kim; Ji Eun Lee; Kyeong Min Min; Sung Joon Kim
Journal:  J Korean Med Sci       Date:  2005-04       Impact factor: 2.153

Review 9.  New pharmacological approaches to the cholinergic system: an overview on muscarinic receptor ligands and cholinesterase inhibitors.

Authors:  Nigel H Greig; Marcella Reale; Ada M Tata
Journal:  Recent Pat CNS Drug Discov       Date:  2013-08

Review 10.  Cholinergic Targets in Lung Cancer.

Authors:  Eliot R Spindel
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.